These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16469497)

  • 1. Antimicrobials: targeting virulence genes necessary for intracellular multiplication.
    Liautard JP; Jubier-Maurin V; Boigegrain RA; Köhler S
    Trends Microbiol; 2006 Mar; 14(3):109-13. PubMed ID: 16469497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical tools for dissecting bacterial physiology and virulence.
    Stanley SA; Hung DT
    Biochemistry; 2009 Sep; 48(37):8776-86. PubMed ID: 19653697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting virulence: a new paradigm for antimicrobial therapy.
    Clatworthy AE; Pierson E; Hung DT
    Nat Chem Biol; 2007 Sep; 3(9):541-8. PubMed ID: 17710100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from signature-tagged mutagenesis on the infectious mechanisms of pathogenic bacteria.
    Autret N; Charbit A
    FEMS Microbiol Rev; 2005 Sep; 29(4):703-17. PubMed ID: 16102599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging bacterial enzyme targets.
    Su Z; Honek JF
    Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches to bacterial infection therapy by interfering with cell-to-cell signaling.
    Rasko DA; Sperandio V
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.3. PubMed ID: 19235150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial genomics and pathogen evolution.
    Raskin DM; Seshadri R; Pukatzki SU; Mekalanos JJ
    Cell; 2006 Feb; 124(4):703-14. PubMed ID: 16497582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New generation of peptide antibiotics.
    Dubin A; Mak P; Dubin G; Rzychon M; Stec-Niemczyk J; Wladyka B; Maziarka K; Chmiel D
    Acta Biochim Pol; 2005; 52(3):633-8. PubMed ID: 16175238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel pathogenicity genes by PCR signature-tagged mutagenesis and related technologies.
    Lehoux DE; Sanschagrin F; Kukavica-Ibrulj I; Potvin E; Levesque RC
    Methods Mol Biol; 2004; 266():289-304. PubMed ID: 15148424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity islands and the evolution of bacterial pathogens.
    Lee CA
    Infect Agents Dis; 1996 Jan; 5(1):1-7. PubMed ID: 8789594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signature-tagged mutagenesis: technical advances in a negative selection method for virulence gene identification.
    Saenz HL; Dehio C
    Curr Opin Microbiol; 2005 Oct; 8(5):612-9. PubMed ID: 16126452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and isolation of Brucella suis virulence genes involved in resistance to the human innate immune system.
    Liautard J; Ouahrani-Bettache S; Jubier-Maurin V; Lafont V; Köhler S; Liautard JP
    Infect Immun; 2007 Nov; 75(11):5167-74. PubMed ID: 17709411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black holes, antivirulence genes, and gene inactivation in the evolution of bacterial pathogens.
    Maurelli AT
    FEMS Microbiol Lett; 2007 Feb; 267(1):1-8. PubMed ID: 17233672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structurally refined beta-lactones as potent inhibitors of devastating bacterial virulence factors.
    Böttcher T; Sieber SA
    Chembiochem; 2009 Mar; 10(4):663-6. PubMed ID: 19206121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial adhesion and entry into host cells.
    Pizarro-Cerdá J; Cossart P
    Cell; 2006 Feb; 124(4):715-27. PubMed ID: 16497583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of microbial virulence: the benefits of stress.
    Arnold DL; Jackson RW; Waterfield NR; Mansfield JW
    Trends Genet; 2007 Jun; 23(6):293-300. PubMed ID: 17434232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disarming pathogens: benefits and challenges of antimicrobials that target bacterial virulence instead of growth and viability.
    Totsika M
    Future Med Chem; 2017 Mar; 9(3):267-269. PubMed ID: 28207349
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of virulence factors of pathogenic bacteria.
    Wu HJ; Wang AH; Jennings MP
    Curr Opin Chem Biol; 2008 Feb; 12(1):93-101. PubMed ID: 18284925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postgenomic analysis of bacterial pathogens repertoire reveals genome reduction rather than virulence factors.
    Merhej V; Georgiades K; Raoult D
    Brief Funct Genomics; 2013 Jul; 12(4):291-304. PubMed ID: 23814139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.